Pfizer Earnings, Revenue Beat in Q1 By Investing.com


© Reuters. Pfizer Earnings, Revenue Beat in Q1

Investing.com – Pfizer (NYSE:) reported on Tuesday first quarter that beat analysts’ forecasts and revenue that topped expectations.

Pfizer announced earnings per share of $1.62 on revenue of $25.66B. Analysts polled by Investing.com anticipated EPS of $1.52 on revenue of $24.1B.

Pfizer shares are down 5% from the beginning of the year, still down 21.67% from its 52 week high of $61.71 set on December 20, 2021. They are outperforming the S&P 500 which is down 12.82% from the start of the year.

Pfizer follows other major Healthcare sector earnings this month

Pfizer’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.

J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar

Be the first to comment

Leave a Reply

Your email address will not be published.


*